Targeting human dendritic cells via DEC-205 using PLGA nanoparticles leads to enhanced cross-presentation of a melanoma-associated antigen

International journal of nanomedicine

Volumn 9, Issue , 2014, Pages 5231-5246

  Saluja, Sandeep S ^a   Hanlon, Douglas J ^a   Sharp, Fiona A ^b   Hong, Enping ^a   Khalil, David ^a   Robinson, Eve ^a   Tigelaar, Robert ^a   Fahmy, Tarek M ^a   Edelson, Richard L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Yale University   (United States)

Author keywords

cross presentation; DEC 205; dendritic cells; melanoma associated antigen; PLGA nanoparticles

Indexed keywords

CANCER VACCINE; CELL SURFACE RECEPTOR; DEC-205 RECEPTOR; LACTIC ACID; LECTIN; LEUKOCYTE ANTIGEN; MELAN A; MLANA PROTEIN, HUMAN; NANOPARTICLE; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ANTIGEN PRESENTATION; CHEMISTRY; DENDRITIC CELL; DRUG EFFECTS; HUMAN; IMMUNOLOGY; MELANOMA; MOLECULARLY TARGETED THERAPY;

ANTIGEN PRESENTATION; ANTIGENS, CD; CANCER VACCINES; DENDRITIC CELLS; HUMANS; LACTIC ACID; LECTINS, C-TYPE; MART-1 ANTIGEN; MELANOMA; MOLECULAR TARGETED THERAPY; NANOPARTICLES; POLYGLYCOLIC ACID; RECEPTORS, CELL SURFACE;

EID: 84944228684     PISSN: None     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S66639     Document Type: Article

References (0)